Patents by Inventor James Hackett
James Hackett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230385843Abstract: A method of approving expenditures in real-time, comprising receiving an expenditure request initiated by a user associated with an organization for transferring funds of the organization in exchange for one or more products and/or services, identifying request attribute(s) relating to the user, the value, the funds, the product, the service, a time of reception of the expenditure request and/or a geographical location of the user, analyzing scheduling data obtained from one or more online data sources which is indicative of one or more activity attributes of activity(s) scheduled for the user, automatically determining compliance between the request attribute(s) and one or more expenditure rules predefined for the product(s) and/or service(s) with respect to the activity attribute(s) and transmitting a response to the expenditure request according to the determination which includes approval of the expenditure request in case of compliance and rejection in case of incompliance.Type: ApplicationFiled: August 10, 2023Publication date: November 30, 2023Applicant: Custodia Inc.Inventors: Elad EFRAIM, Jonathan HELLER, James HACKETT
-
Publication number: 20230376966Abstract: A method of approving expenditures in real-time, comprising receiving an expenditure request initiated by a user associated with an organization for transferring funds of the organization in exchange for one or more products and/or services, identifying request attribute(s) relating to the user, the value, the funds, the product, the service, a time of reception of the expenditure request and/or a geographical location of the user, analyzing scheduling data obtained from one or more online data sources which is indicative of one or more activity attributes of activity(s) scheduled for the user, automatically determining compliance between the request attribute(s) and one or more expenditure rules predefined for the product(s) and/or service(s) with respect to the activity attribute(s) and transmitting a response to the expenditure request according to the determination which includes approval of the expenditure request in case of compliance and rejection in case of incompliance.Type: ApplicationFiled: August 8, 2023Publication date: November 23, 2023Applicant: Custodia Inc.Inventors: Elad EFRAIM, Jonathan HELLER, James HACKETT
-
Publication number: 20230376965Abstract: A method of approving expenditures in real-time, comprising receiving an expenditure request initiated by a user associated with an organization for transferring funds of the organization in exchange for one or more products and/or services, identifying request attribute(s) relating to the user, the value, the funds, the product, the service, a time of reception of the expenditure request and/or a geographical location of the user, analyzing scheduling data obtained from one or more online data sources which is indicative of one or more activity attributes of activity(s) scheduled for the user, automatically determining compliance between the request attribute(s) and one or more expenditure rules predefined for the product(s) and/or service(s) with respect to the activity attribute(s) and transmitting a response to the expenditure request according to the determination which includes approval of the expenditure request in case of compliance and rejection in case of incompliance.Type: ApplicationFiled: August 8, 2023Publication date: November 23, 2023Applicant: Custodia Inc.Inventors: Elad EFRAIM, Jonathan HELLER, James HACKETT
-
Patent number: 11756041Abstract: A method of approving expenditures in real-time, comprising receiving an expenditure request initiated by a user associated with an organization for transferring funds of the organization in exchange for one or more products and/or services, identifying request attribute(s) relating to the user, the value, the funds, the product, the service, a time of reception of the expenditure request and/or a geographical location of the user, analyzing scheduling data obtained from one or more online data sources which is indicative of one or more activity attributes of activity(s) scheduled for the user, automatically determining compliance between the request attribute(s) and one or more expenditure rules predefined for the product(s) and/or service(s) with respect to the activity attribute(s) and transmitting a response to the expenditure request according to the determination which includes approval of the expenditure request in case of compliance and rejection in case of incompliance.Type: GrantFiled: June 11, 2019Date of Patent: September 12, 2023Assignee: Custodia Inc.Inventors: Elad Efraim, Jonathan Heller, James Hackett
-
Publication number: 20190378136Abstract: A method of approving expenditures in real-time, comprising receiving an expenditure request initiated by a user associated with an organization for transferring funds of the organization in exchange for one or more products and/or services, identifying request attribute(s) relating to the user, the value, the funds, the product, the service, a time of reception of the expenditure request and/or a geographical location of the user, analyzing scheduling data obtained from one or more online data sources which is indicative of one or more activity attributes of activity(s) scheduled for the user, automatically determining compliance between the request attribute(s) and one or more expenditure rules predefined for the product(s) and/or service(s) with respect to the activity attribute(s) and transmitting a response to the expenditure request according to the determination which includes approval of the expenditure request in case of compliance and rejection in case of incompliance.Type: ApplicationFiled: June 11, 2019Publication date: December 12, 2019Applicant: Custodia Inc.Inventors: Elad EFRAIM, Jonathan HELLER, James HACKETT
-
Patent number: 8906625Abstract: The invention concerns genes that have been identified as being involved in estrogen metabolism, and are useful as diagnostic, prognostic and/or predictive markers in cancer. In particular, the invention concerns genes the tumor expression levels of which are useful in the diagnosis of cancers associated with estrogen metabolism, and/or in the prognosis of clinical outcome and/or prediction of drug response of such cancers.Type: GrantFiled: December 17, 2010Date of Patent: December 9, 2014Assignee: Genomic Health, Inc.Inventors: Michael C. Kiefer, Joffre B. Baker, James Hackett
-
Patent number: 8808994Abstract: The invention concerns genes that have been identified as being involved in estrogen metabolism, and are useful as diagnostic, prognostic and/or predictive markers in cancer. In particular, the invention concerns genes the tumor expression levels of which are useful in the diagnosis of cancers associated with estrogen metabolism, and/or in the prognosis of clinical outcome and/or prediction of drug response of such cancers.Type: GrantFiled: December 17, 2010Date of Patent: August 19, 2014Assignee: Genomic Health, Inc.Inventors: Michael C. Kiefer, Joffre B. Baker, James Hackett
-
Publication number: 20140206545Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.Type: ApplicationFiled: December 18, 2013Publication date: July 24, 2014Applicants: NSABP FOUNDATION, INC., GENOMIC HEALTH, INC.Inventors: Joffre B. BAKER, Wayne COWENS, Kim M. CLARK-LANGONE, James HACKETT, Drew WATSON, Soonmyung PAIK
-
Patent number: 8632980Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.Type: GrantFiled: October 21, 2011Date of Patent: January 21, 2014Assignees: Genomic Health, Inc., NSABP Foundation, IncInventors: Joffre B. Baker, Wayne Cowens, Kim Langone, James Hackett, Drew Watson, Soonmyung Paik
-
Patent number: 8367345Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: March 6, 2012Date of Patent: February 5, 2013Assignees: Genomic Health Inc., NSABP Foundation, Inc.Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark-Langane, James Hackett, Drew Watson, Soonmyung Paik
-
Patent number: 8273537Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: October 25, 2010Date of Patent: September 25, 2012Assignees: Genomic Health, Inc., NSABP Foundation, Inc.Inventors: Drew Watson, Soonmyung Paik, Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett
-
Publication number: 20120171688Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: ApplicationFiled: March 6, 2012Publication date: July 5, 2012Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark-Langane, James Hackett, Drew Watson, Soonmyung Palk
-
Patent number: 8198024Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: January 19, 2011Date of Patent: June 12, 2012Assignees: Genomic Health, Inc., NSABP Foundation, Inc.Inventors: Drew Watson, Soonmyung Paik, Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett
-
Patent number: 8153378Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: January 29, 2010Date of Patent: April 10, 2012Assignees: Genomic Health, Inc., NSABP Foundations, Inc.Inventors: Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett, Drew Watson, Soonmyung Paik
-
Patent number: 8153379Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: October 25, 2010Date of Patent: April 10, 2012Assignees: Genomic Health, Inc., NSABP Foundation, Inc.Inventors: Drew Watson, Soonmyung Paik, Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett
-
Patent number: 8153380Abstract: A method of predicting clinical outcome in a subject diagnosed with colorectal cancer comprising determining evidence of the expression of one or more predictive RNA transcripts or their expression products in a biological sample of cancer cells obtained from the subject.Type: GrantFiled: October 25, 2010Date of Patent: April 10, 2012Assignees: Genomic Health, Inc., NSABP Foundation, Inc.Inventors: Drew Watson, Soonmyung Paik, Wayne Cowens, Joffre B. Baker, Kim Clark, James Hackett
-
Publication number: 20120040842Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.Type: ApplicationFiled: October 21, 2011Publication date: February 16, 2012Inventors: Joffre B. Baker, Wayne Cowens, Kim Langone, James Hackett, Drew Watson, Soonmyung Paik
-
Patent number: 8067178Abstract: The present invention relates to gene sets useful in assessing prognosis and/or predicting the response of cancer, e.g. colorectal cancer to chemotherapy. In addition, the invention relates to a clinically validated cancer test, e.g. colorectal test, for assessment of prognosis and/or prediction of patient response to chemotherapy, using expression analysis. The present invention accommodates the use of archived paraffin embedded biopsy material for assay of all markers in the relevant gene sets and therefore is compatible with the most widely available type of biopsy material.Type: GrantFiled: March 13, 2009Date of Patent: November 29, 2011Assignees: Genomic Health, Inc., NSABP Foundation, Inc.Inventors: Joffre B. Baker, Wayne Cowens, Kim Langone, James Hackett, Drew Watson, Soonmyung Paik
-
Publication number: 20110275082Abstract: The invention concerns genes that have been identified as being involved in estrogen metabolism, and are useful as diagnostic, prognostic and/or predictive markers in cancer. In particular, the invention concerns genes the tumor expression levels of which are useful in the diagnosis of cancers associated with estrogen metabolism, and/or in the prognosis of clinical outcome and/or prediction of drug response of such cancers.Type: ApplicationFiled: December 17, 2010Publication date: November 10, 2011Inventors: MICHAEL C. KIEFER, JOFFRE B. BAKER, JAMES HACKETT
-
Patent number: D693660Type: GrantFiled: January 15, 2013Date of Patent: November 19, 2013Inventors: James L. Hackett, Michael James Hackett